Beranda › Penyakit Kardiovaskular › Tennessee › Nashville
Uji klinis Penyakit Kardiovaskular di Nashville, TN
18 studi untuk Penyakit Kardiovaskular mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Menerima pesertaFase 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Menerima peserta
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Menerima peserta
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
Menerima pesertaStudi observasional
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Menerima peserta
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Menerima pesertaFase 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Menerima peserta
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Menerima pesertaFase 4Sukarelawan sehat diterima
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Menerima pesertaFase 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Menerima pesertaFase 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Menerima pesertaFase 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
Menerima pesertaStudi observasional
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Menerima peserta
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Menerima pesertaFase 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Menerima peserta
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
Menerima pesertaFase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
Menerima pesertaStudi observasional
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Menerima peserta
- Centennial Medical Center, Nashville
Uji klinis Penyakit Kardiovaskular di kota lain
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC28 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Cleveland, OH22 studi
- Atlanta, GA22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- Los Angeles, CA18 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.